Literature DB >> 17115268

Osteoclastic differentiation and function regulated by old and new pathways.

Harry C Blair1, Mone Zaidi.   

Abstract

The osteoclast is a specialized multinucleated variant of the macrophage family. It degrades mineralized tissue, and is required for modeling and remodeling of bone. The osteoclast has long been known to require vitamin D for its differentiation and to be regulated by parathyroid hormone via circulating Ca(2+) levels. Two local signals important in osteoclast survival and differentiation, CSF-1 and RANKL, were characterized by the mid-1990 s. A basic framework of specialized cell attachment and resorption molecules was also clear by that time, including the alpha(v)beta(3) integrin, the key adhesion molecule of the mature osteoclast, the highly expressed vacuolar-type H(+)-ATPase that drives acid secretion to dissolve mineral, and cathepsin K, the predominant acid proteinase for collagenolysis. Recently, additional detail has been added to this framework, showing that the osteoclast has more complex regulation than was previously believed. These include the findings that one component of the V-H(+)-ATPase is unique to the osteoclast, that chloride transport and probably Cl(-)/H(+) exchange are also required for mineral degradation, and that additional receptors besides RANK and Fms regulate osteoclast formation and survival. Additional receptors include estrogen receptor-alpha, TNF-family receptors other than RANK, and, at least in some cases, glycoprotein hormone receptors including the TSH-R and the FSH-R. Challenges in understanding osteoclast biology include how the signalling mechanisms function cooperatively. Recent findings suggest that there is a network of cytoplasmic adapters, including Gab-2 and BCAR1, which are modified by multiple signalling mechanisms and which serve to integrate the signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115268     DOI: 10.1007/s11154-006-9010-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   9.306


  112 in total

1.  Age-related thymic activity in adults following chemotherapy-induced lymphopenia.

Authors:  P P Sfikakis; G M Gourgoulis; L A Moulopoulos; G Kouvatseas; A N Theofilopoulos; M A Dimopoulos
Journal:  Eur J Clin Invest       Date:  2005-06       Impact factor: 4.686

2.  Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

Authors:  Ana O Hoff; Philip Catala-Lehnen; Pamela M Thomas; Matthias Priemel; Johannes M Rueger; Igor Nasonkin; Allan Bradley; Mark R Hughes; Nelson Ordonez; Gilbert J Cote; Michael Amling; Robert F Gagel
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells.

Authors:  Clare C Davies; Tak W Mak; Lawrence S Young; Aristides G Eliopoulos
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  Characterization of a Ca2(+)-ATPase in osteoclast plasma membrane.

Authors:  P J Bekker; C V Gay
Journal:  J Bone Miner Res       Date:  1990-06       Impact factor: 6.741

6.  The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.

Authors:  Teiji Wada; Tomoki Nakashima; Antonio J Oliveira-dos-Santos; Juerg Gasser; Hiromitsu Hara; Georg Schett; Josef M Penninger
Journal:  Nat Med       Date:  2005-03-06       Impact factor: 53.440

7.  The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

Authors:  Attila Mócsai; Mary Beth Humphrey; Jessica A G Van Ziffle; Yongmei Hu; Andrew Burghardt; Steven C Spusta; Sharmila Majumdar; Lewis L Lanier; Clifford A Lowell; Mary C Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

8.  M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.

Authors:  H Glantschnig; J E Fisher; G Wesolowski; G A Rodan; A A Reszka
Journal:  Cell Death Differ       Date:  2003-10       Impact factor: 15.828

Review 9.  Podosomes as smart regulators of cellular adhesion.

Authors:  Laura Spinardi; Pier Carlo Marchisio
Journal:  Eur J Cell Biol       Date:  2005-09-19       Impact factor: 4.492

10.  Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene.

Authors:  A Teti; A Taranta; S Migliaccio; A Degiorgi; E Santandrea; I Villanova; T Faraggiana; M Chellaiah; K A Hruska
Journal:  J Bone Miner Res       Date:  1998-01       Impact factor: 6.741

View more
  17 in total

1.  Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer.

Authors:  J Adriaansen; P Perez; C Zheng; M T Collins; B J Baum
Journal:  Hum Gene Ther       Date:  2011-01-03       Impact factor: 5.695

Review 2.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

3.  Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Authors:  Julia Barsony; Yoshihisa Sugimura; Joseph G Verbalis
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Production and sorting of transgenic, modified human parathyroid hormone in vivo in rat salivary glands.

Authors:  Janik Adriaansen; Changyu Zheng; Paola Perez; Bruce J Baum
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

5.  Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors:  Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

6.  Differential sorting of human parathyroid hormone after transduction of mouse and rat salivary glands.

Authors:  J Adriaansen; P Perez; C M Goldsmith; C Zheng; B J Baum
Journal:  Hum Gene Ther       Date:  2008-10       Impact factor: 5.695

7.  Deletion of mitogen-activated protein kinase phosphatase 1 modifies the response to mechanical bone marrow ablation in a mouse model.

Authors:  Jodi Carlson; Qing Zhang; Anton Bennett; Agnès Vignery
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

8.  Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression.

Authors:  Zhi-feng Wei; Xiao-lan Jiao; Ting Wang; Qian Lu; Yu-feng Xia; Zheng-tao Wang; Qing-long Guo; Gui-xin Chou; Yue Dai
Journal:  Acta Pharmacol Sin       Date:  2013-02-11       Impact factor: 6.150

9.  Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.

Authors:  Lisa J Robinson; Beatrice B Yaroslavskiy; Reed D Griswold; Eva V Zadorozny; Lida Guo; Irina L Tourkova; Harry C Blair
Journal:  Exp Cell Res       Date:  2009-01-30       Impact factor: 3.905

10.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.